Government-backed Protemix in liquidation
Biopharmaceutical firm Protemix has gone into liquidation owing $2.15 million to creditors after burning through $61 million of shareholder funds.The liquidation is a sad end to what had been a highly promising venture set up by Professor Garth Cooper and
Duncan Bridgeman
Mon, 19 Jul 2010
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Biopharmaceutical firm Protemix has gone into liquidation owing $2.15 million to creditors after burning through $61 million of shareholder funds.
The liquidation is a sad end to what had been a highly promising venture set up by Professor Garth Cooper and John Baker 15 years ago.
Protemix had
Want to read more? It's easy.
Choose your subscription
Already have an account? Login
Smartphone Only Subscription
NZ$29.95 / monthly
Subscribe Now
Monthly Premium Online Subscription
NZ$49.95 / monthly
Subscribe Now
Smartphone Only Annual Subscription
NZ$299.00 / yearly
Subscribe Now
Yearly Premium Online Subscription
NZ$499.00 / yearly
Subscribe Now
Premium Group Membership 10 Users
NZ$385+GST / monthly
$38.5 per user - Pay by monthly
credit card debit
Subscribe Now
Premium Group Membership 20 Users
NZ$660+GST / monthly
$33 per user - Pay by monthly
credit card debit
Subscribe Now
Premium Group Membership 50 Users
NZ$1375+GST / monthly
$27.5 per user - Pay by monthly
credit card debit
Subscribe Now
Premium Group Membership 100 Users
NZ$2100+GST / monthly
$21 per user - Pay by monthly
credit card debit
Subscribe Now
Yearly Premium Online Subscription + NBR Marketplace
NZ$999.00 / yearly
Subscribe Now
Individual
Group membership
NBR Marketplace
Student
Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).
Duncan Bridgeman
Mon, 19 Jul 2010
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
